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Abstract
Background: The identification of molecular pathways of differentiation of embryonic stem cells
(hESC) is critical for the development of stem cell based medical therapies. In order to identify
biomarkers and potential regulators of the process of differentiation, a high quality microarray
containing 16,659 seventy base pair oligonucleotides was used to compare gene expression profiles
of undifferentiated hESC lines and differentiating embryoid bodies.
Results:  Previously identified "stemness" genes in undifferentiated hESC lines showed down
modulation in differentiated cells while expression of several genes was induced as cells
differentiated. In addition, a subset of 194 genes showed overexpression of greater than ≥ 3 folds
in human embryoid bodies (hEB). These included 37 novel and 157 known genes. Gene expression
was validated by a variety of techniques including another large scale array, reverse transcription
polymerase chain reaction, focused cDNA microarrays, massively parallel signature sequencing
(MPSS) analysis and immunocytochemisty. Several novel hEB specific expressed sequence tags
(ESTs) were mapped to the human genome database and their expression profile characterized. A
hierarchical clustering analysis clearly depicted a distinct difference in gene expression profile
among undifferentiated and differentiated hESC and confirmed that microarray analysis could
readily distinguish them.
Conclusion: These results present a detailed characterization of a unique set of genes, which can
be used to assess the hESC differentiation.
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Background
Embryonic stem cells (hESC) have been isolated from
multiple species [1-4] including non-human primates [2]
and humans [3,4]. Currently, over hundred different
Human embryonic stem cell (hESC) lines have been
established [3-7]. hESC populations grow as tightly com-
pacted colonies of undifferentiated cells on mouse [3,4]
or human [6] feeders or as colonies in feeder-free condi-
tions using matrix and conditioned medium [8]. hESC
has been shown to differentiate in vitro and in vivo to
form derivates of all three germ layers. In vitro differenti-
ation can be induced by the process of embryoid body
(hEB) formation, which involves aggregating the cells and
preventing separation by plating on a non-permissive sub-
strate. Cell to cell interaction and addition of differentia-
tion agents such as retinoic acid (RA) induces
differentiation into derivatives of all three germ layers
(mesoderm, ectoderm and endoderm) [7,9-12].
hEB can subsequently be induced to undergo further dif-
ferentiation to generate a variety of cell types, including
hematopoietic [13], neuronal [14,15], myogenic [16] and
cardiac muscle cells [17,18]. Thus, hEB represent an early
stage in the process of lineage specification and should
differ from hESC or their more differentiated progeny in
their profile of gene expression.
Several different methods have been developed that can
be used to assess the process of differentiation. Subtractive
hybridization [19,20], differential display polymerase
chain reaction (DD-PCR) [21], representational differ-
ence analysis (RDA) [22], analysis of expressed sequence
tag (EST) [23] and serial analyses of gene expression
(SAGE) [24] are but a few commonly used techniques.
Perhaps the most commonly used however, is gene array
(microarray) [25-27]. Microarrays have been used by sev-
eral investigators to assess the undifferentiated hESC state
[28,29] and provide a data set of useful information. We
for example utilized a large-scale oligonucleotide based
array to identify a set of 92 genes that are highly upregu-
lated in six hESC lines when compared against human
universal reference RNA derived from mature tissues [28].
This set of "stemness genes" along with additional novel
genes identified has served to assess the state of undiffer-
entiated cells. However, currently no similar data set is
available for genes that may be used to define the embry-
oid body stage of hESC differentiation and no compari-
sons between the undifferentiated and differentiated
populations have been performed utilizing microarray
technology. A recent study has characterized gene expres-
sion in embryoid bodies by massively parallel signature
sequencing (MPSS) and suggested that several candidate
genes specific to hEB may exist [30]. MPSS analysis how-
ever, is expensive and unavailable for most laboratories.
Therefore, an alternate readily available and economical
assay is needed to characterize embryoid bodies and com-
pare them with available datasets on hESC. Microarray
studies of hEB's offer the possibility of such an assay that
can be used for routine assessment of the state of ES cell
differentiation.
To determine if microarrays (or gene arrays) can be used
to distinguish between hESC and hEB and to identify can-
didate markers of the process of differentiation we have
compared the gene expression pattern of undifferentiated
hESC and differentiated hEB derived from them using a
large-scale oligonucleotide based arrays. The expression of
selected genes was confirmed by another large-scale array,
reverse transcriptase-polymerase chain reaction (RT-PCR),
comparison with an expressed sequence tag (EST) enu-
meration database of ESC [23], MPSS data from embryoid
bodies [30] and immunocytochemistry. Our results show
that microarray studies can readily distinguish between
hESC and hEB and can be used to identify markers of the
embryoid body stage.
Results
Microarray detects differences between hESC and hEB 
derived from them
To assess alteration in gene expression in hESC and hEBs,
cells were cultured and induced to form EBs (Fig. 1). Total
RNA was harvested from undifferentiated hESCs and hEBs
derived from them and a time course of gene expression
was performed to assess downregulation of known ES cell
specific genes. Day 13 of differentiation was chosen as a
time point for subsequent analysis where there is a clear
downregulation of known hESC markers and an upregu-
lation of some early markers of differentiation (Fig. 2).
The expression of known undifferentiated hESC markers
including Oct4, Nanog and Esg1 showed reduction in
expression in hEB at day 13 while known markers of dif-
ferentiation (SOX1, Nestin, and GATA4) showed a
marked increase in expression. Several genes (Sox2, TERT,
BCRP, Cx43, and Rex-1) did not show detectable change
between hESC and hEB cells. For microarray studies each
sample was compared to human universal reference RNA
(mixture of total RNAs from a collection of adult human
cell lines, chosen to represent a broad range of expressed
genes and both male and female donors are represented)
to maintain uniformity and allow comparisons across
samples. cDNA from BG02 and pooled samples of hESC
were labeled with Cy5 and huURNA with Cy3, and
~17,000 oligonucleotide arrays were hybridized. Simi-
larly, cDNA from hEB derived from differentiated BG02-
ESC (day 13 BG02 EB, day 21 BG02 EB) and pooled
WiCell EB (day 13) was labeled with Cy5 and huURNA
with Cy3 and arrays were hybridized and data analyzed.
Since the process of differentiation is relatively stochastic
and cell lines may behave differently as they differentiate,
data from different experiments (with different samples)BMC Developmental Biology 2005, 5:22 http://www.biomedcentral.com/1471-213X/5/22
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was not pooled and reported as the expression from single
hybridization. Each sample was analyzed in duplicate
obtained from two different independent cultures.
Overall microarray results between technical replicates
were similar and representative images from each experi-
ment are available (see Additional file-1, 2, 3, 4, 5). Micro-
array analysis showed that 11,000 of the ~17,000 features
present on the array were detectable above background at
a ≥ 150 minimum intensity and target pixels of one stand-
ard deviation (SD) above background (≥30) cutoffs. hEB
and hESC expressed approximately 2400 to 3000 genes.
Pooled WiCell ESC and BG02 ESC showed over expres-
sion of 2471 and 2843 genes at ≥ 2 fold respectively, com-
pared to huURNA (Supplementary Table-1Sa and 1Sb, see
additional file-6 and 7). As these cells differentiated to
hEB, the number of total genes that were detected
remained similar to hESC (supplementary Table 2S, see
additional file-8).
For some experiments ESC samples were pooled as we
were interested in identifying differences between ESC
and EBs that would be common to multiple lines. Further,
as EB formation is variable we felt pooling may allow us
to focus on large differences which would not be lost in
the averaging process. Once we obtained results we then
tested if this was true by using cell line provided by a dif-
ferent provider and propagated under different culture
condition. In addition, since the purpose of day 21 differ-
entiation was to study which genes persisted and which
were modulated as a result of further differentiation we
did not use day 21 pooled EBs but focused on results from
a single line
We have previously shown that six hESC lines (BG02,
BG01, GE01, GE09, TE06 and PES cell lines from GE01,
GE07 and GE09) express 92 genes in common at ≥ 3 fold
levels when compared with huURNA (28). We therefore
examined the expression of these genes and in addition all
genes overexpressed in BG02 and pooled hESCs (Table 1/
see additional file-9) (supplementary Table 1Sa and 1Sb,
see additional file 6 and 7). Eighty-seven of 92 genes were
also detected in the present sample confirming the quality
of the array hybridization and the fidelity of the samples
used. In addition, previous study identified several early
markers of differentiation, that were present at low levels
in hESC and when hESC cells were differentiated, these
genes were upregulated and up regulation was confirmed
by EST enumeration technique [28]. The present study
confirmed these earlier observations by microarray exper-
iments (Table2/see additional file 9). These differentia-
tion genes included Keratin 8, Keratin 18, ACTC, and
TUBB5. When we examined our current results, we found
that these genes were also up regulated in hEB cells
derived from BG02 and WiCell lines by microarray studies
(Table 2/ see additional file 9). These results confirm the
EST enumeration data and further provide support for the
quality of hEBs used.
Phase differentiation of ES and EB Figure 1
Phase differentiation of ES and EB. Phase pictures of a human ES cell clone grown under feeder-free conditions (A) and a 
human EB of day 14 (B).BMC Developmental Biology 2005, 5:22 http://www.biomedcentral.com/1471-213X/5/22
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Overall the technical replicates, the testing of the expres-
sion of known genes and the ability to detect expected
changes in the current samples confirmed the suitability
of the current data set for additional analysis.
Modulation of "stemness genes by ES cell differentiation
Previously, we identified a set of 92 genes are expressed at
high levels in most hESC and can be detected by
microarray and EST enumeration [28]. To test if changes
in their expression could be used to monitor differentia-
tion, we examined the relative levels of these genes as ES
cell differentiated. Eighty-seven of the 92 genes expressed
in all six hESC lines were also over expressed in day 13
BGO2-EB and day 13 pooled WiCell EB compared to
HuURNA (data not shown). However, as a result of differ-
entiation of the BG02-ESC line 77 out of 92 genes were
down modulated in BG02 EB cells (Table 1/ see addi-
tional file 9). Among these, known ES cell markers e.g.,
POU5F1, GTCM-1, LEFTB, Galanin, GJA1, TDGF1, SFRP2,
FABP5 and Lin-28 showed a marked decline in their
expression compared to undifferentiated ES cells. Simi-
larly, other ES cell specific markers such as CER1 and
DNMT3B also showed marked decline in the expression
in day 13 BG02 EB compared to ESC (Table1/ see addi-
tional file 9). However, three zinc finger proteins did not
show any significant change and down modulation of
Numatrin, C20orf129 and Laminin receptor was modest
(Table1/ see additional file 9).
Twelve novel genes that were overexpressed in all 6 hESC
lines tested [28], were all down modulated by differentia-
tion. Among them MGC27165 (IFITM1), GSH1, PPAT,
KIAA1573, TD-60, C20orf168, ARL8 showed a marked
decline in fold expression in BG02 EB compared to undif-
ferentiated BG02 (Table 1/ see additional file 9) while
changes in other genes was modest.
Pooled EB samples of ES cells (WA01, WA07 and WA09)
showed a similar gene expression profile as observed in
day 13 BG02-EB. 53 out of 92 "stemness" genes were
down modulated compared to undifferentiated WiCell
ESC (Table 1/ see additional file 9). These 53 genes were a
subset of the 77 that were markedly downmodulated in
BG02 derived EB compared to undifferentiated BG02-ESC
(see above and Table 1/ see additional file 9). POU5F1,
LEFTB, FABP5, Galanin, GJA1, SFRP2, Nanog and TDGF1
ES specific genes showed ≥ 3 times lower expression in
pooled WiCell EB compared to pooled WiCell ESC (Table
1/ see additional file 9). In addition, other ES cell specific
markers like DNMT3B, CER1, and SOX2 also showed
down modulation in pooled WiCell EB. Novel genes such
as PPAT, MGC27165, GSH1, ARL8, and KIAA1573
showed marked down modulation in pooled EB com-
pared to pooled ES cells. However, zinc finger protein
RT-PCR of some marker genes in pooled samples of ES and  EB RNA Figure 2
RT-PCR of some marker genes in pooled samples of ES and 
EB RNA. RT-PCR analysis of marker genes in Pooled ES and 
pooled EB cell lines. Total RNA derived from both the ES 
and EB cell lines (WiCell lines) were subjected to RT-PCR 
analysis as previously described (34). G3PDH mRNA ampli-
fied from these samples served as an internal control. The 
primers used are listed in supplementary table (Table 7S). 
The thermocycler conditions used for amplification were 
94°C, 4 minutes hot start,94°C, 30 sec; 60°C, 30 sec and 
72°C, 1 minute. Ten microliter amplification products were 
resolved in 2% agarose gel, stained with ethidium bromide 
(EtBr), and visualized in a transilluminator and photographed.BMC Developmental Biology 2005, 5:22 http://www.biomedcentral.com/1471-213X/5/22
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Znf257, laminin receptor, C20orf1 and C20orf129
showed modest decline (Table 1/ see additional file 9).
Both pooled WiCell EB and day 13 BG02-EB showed an
upregulation of genes that we had previously identified as
being markers of differentiation that were present in
detectable levels in undifferentiated hESC lines (Table 2/
see additional file 9). These included early differentiation
markers e.g., KRT8, KRT18, TUBB5 and ACTC. Overall,
the pattern of differentiation appeared similar with BG02
when compared to embryoid bodies derived from WiCell
ESC.
Among 92 genes, thirteen additional novel genes have
been identified previously in hESC [28]. However, only 3
of the thirteen genes were present on this array and their
expression was analyzed. Our results show that Dppa4
was expressed in BG02 ES and pooled WiCell ES, how-
ever, its expression level was eight fold higher in day 13
BG02 EB compared to huURNA and down modulated to
2 fold at day 21 BG02-EB. Similarly, pooled WiCell hESC
cells showed 10 fold over expression of Dppa4 compared
to HuURNA, however upon differentiation to EB the
expression was decreased. In sharp contrast, claudin-6
showed down modulation of expression from pooled
WiCell ESC to EB by about 10 fold but was not present in
detectable levels in either BG02 ES or BG02 EBs.
In PEB some genes that showed down modulation in
BG02 EBs were in fact up regulated compared to ESC. The
reason for this reverse pattern is not known. Although we
did not check whether these were also up regulated in day
21 pooled EBs, our future studies are focused on address-
ing these issues. It is possible that a mixture of three hESC
lines behaved differently when they were mixed and
differentiated.
Overall, these data confirm that seventy-seven of the
ninety-two genes we had identified as hESC specific could
be used to assess the differentiation state of ES cells as they
differentiate. A large number of these genes show a dra-
matic down modulation as early as Day 13 and this is seen
in both WiCell and Bresagen (BG02) cell lines and can be
readily assessed by microarray analysis.
Genes that are upregulated as ES cells differentiated to 
form embryoid bodies
To analyze genes that were upregulated as hESC differen-
tiated, embryoid bodies were prepared as previously
described and their quality analyzed as described above.
Samples, which showed a clear downmodulation of ES
cell specific genes, were subjected to microarray studies
and their overall gene expression pattern compared with
that of the undifferentiated population. Each individual
experiment was analyzed separately and differences in
gene expression observed were then compared. When
BG02 hESC were compared with embryoid bodies derived
from them a total of 333 new genes were expressed at ≥ 3
fold higher levels in day 13 BG02-EB compared to undif-
ferentiated BG02 ESC (Supplementary Table 3S, see addi-
tional file-8). These genes included many genes known to
be upregulated in EB cells and confirmed the quality of
the array and the hybridization (see supplementary data).
In addition, we identified numerous additional genes
whose expression in hEBs had not been documented
previously.
Since we were interested in identifying a core set of genes
that are upregulated as ES cells differentiated we com-
pared the pattern of gene upregulation in a second distinct
population of ES cells (WiCell lines) grown under differ-
ent conditions using protocols described previously
[7,31,32]. Out of 333 genes that were upregulated in day
13 BG02 EB 194 genes were also upregulated at ≥ 3 fold
in WiCell derived EB (pooled EB) (Table 3/ see additional
file 9). The remaining 139 genes were also upregulated
but they did not meet the rigorous three fold cutoff crite-
ria. The expression of these 139 genes by other techniques
will be subject of confirmation in future studies.
The common subset of genes, which showed upregulation
at ≥ 3 fold in both BG02 EB and pooled WiCell EBs were
classified by hierarchical clustering. As shown in Fig 3, all
listed genes (a snap shot of 194 genes) were upregulated
in EBs derived either from BG02 or WiCell lines and the
expression levels can be readily distinguished from those
in undifferentiated ESC. These results clearly show a
marked difference in gene expression profile in differenti-
ated compared to undifferentiated ES.
More detailed examination of the genes that were differ-
entially expressed in ESC and EBs indicated multiple sign-
aling pathways are altered. BG02 EB showed over
expression of Keratin 19, Profilin-1, Fibronectin 1,
HAND1, COL1A2, ZAK, COL4A2, BIRC7, NID2, TUBB5,
TMSB4X, PLP2, ENO1 and COL5A2 (Supplementary
table 4S, see additional file-8). Pooled WiCell EB also
showed upregulation of similar genes including HAND1,
KRT19, Fibronectin 1, Profilin1, TMSB4X, Vimentin, Eno-
lase, PLP2, COL4A2, CAPN1, NID2, IVL, ZAK, SPTA1 and
COL1A2, which are related to cell differentiation or
cytoskeleton (Supplementary Table 5S/see additional file
8). Several genes related to cell signaling, cell growth, cell
cycle and metabolic activities were uniquely identified
(see supplementary table 3S or see additional file-8) and
(Table 3/ see additional file 9). For example, Glypican-3,
member of the glypican-related integral membrane prote-
oglycan family (GRIPS) contains a core protein anchored
to the cytoplasmic membrane via a glycosyl phosphati-
dylinositol linkage and plays a role in the control of cellBMC Developmental Biology 2005, 5:22 http://www.biomedcentral.com/1471-213X/5/22
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division and growth regulation was over expressed. Calre-
ticulin (CALR), which can inhibit androgen receptor and
retinoic acid receptor transcriptional activities in vivo, as
well as retinoic acid-induced neuronal differentiation was
over expressed by 5 fold. Cyclin-dependent kinase inhibi-
tor 1C (CDKN1C), an inhibitor of several G1 cyclin/CDK
complexes (Cyclin-E-CDK2, Cyclin-D2-CDK4 and Cyclin-
A-CDK2) and to lesser extent of the mitotic cyclin-B-
CDC2, was over expressed in EBs. Finally, 26
hypothetical, 2 zinc finger proteins and 9 unknown genes
whose functions are still to be determined were also over
expressed in EBs (Supplementary Table 3S and 6S or see
additional file-8) and (Table 4/ see additional file 9).
Hierarchical clustering of a set of genes over expressed in EB but not in ES Figure 3
Hierarchical clustering of a set of genes over expressed in EB but not in ES. Hierarchical clustering of genes overexpressed in 
EB but not in ESC. All 194 genes were clustered; however, a snap shot of some genes is shown due to space limitation. A set 
of genes showing overexpression at ≥ 3 fold cluster together in BG02-EB and pooled EB but differ from BG02-ESC and pooled 
ESC. Color indicates the relative expression levels of each gene, with red indicating higher expression, green indicating negative 
expression and black representing absent expression. The 10 genes as indicated by the arrows can be considered as marker for 
EB as they are either negatively expressed or absent in ESC in most cases but overexpressed in both the EBs.BMC Developmental Biology 2005, 5:22 http://www.biomedcentral.com/1471-213X/5/22
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Overall, these results indicate that 194 genes identified as
upregulated in two different EB cell lines may serve as
early and sensitive markers to monitor ES cell
differentiation.
Confirmation of gene expression profile by microarray, 
MPSS, EST-enumeration, RT-PCR and 
immunohistochemical analyses
To provide independent verification of the results we uti-
lized three different strategies. We compared gene
expression patterns obtained using microarray studies
with the MPSS data set generated by our laboratory using
the pooled ES and EBs derived from them [30]. In addi-
tion, we prepared duplicate samples of BG02 ES and
BG02 derived embryoid bodies and subjected them to a
microarray analysis using a large scale oligonucleotide
array based on a different set of oligonucleotides that were
commercially available (Agilent, Foster city, CA). Finally
we examined a subset of genes that were not validated by
either of these methods by RT-PCR. Of the 194 genes,
which were uniquely over expressed at ≥ 3 fold in both
BG02 and WiCell cell derived EBs 148 genes showed
higher expression in an MPSS analysis of WiCell samples
(data now shown and reference [33]. Overall, comparison
of microarray results with MPSS showed a high concord-
ance in gene expression profile. For example, known ES
cell specific markers including such as POU5F1, Galanin,
DNMT3B, GJA1, LEFTB and TDGF1 showed higher
expression in undifferentiated BG02 and PES cells com-
pared to differentiated BG02 or PEB by both microarray
and MPSS analyses (Table 5/ see additional file 9). Simi-
larly, early ES differentiation markers e.g., KRT8, KRT18,
KRT19, ACTC and EB specific genes such as Vimentin,
AFP, HAND1, and COL1A2 showed higher expression in
EBs compared to ESC by both microarray and EST enu-
meration (Table 6 and Table 7/ see additional file 9).
When fold expression of 8 out of 9 unknown genes iden-
tified by microarray was compared with tpm level
detected by MPSS, a similar pattern of gene expression was
observed (Table 8/ see additional file 9). All of these genes
showed higher expression in BG02-EB and WiCell derived
EB compared to BG02-ES and WiCell ESC samples. Six of
these genes were also confirmed by RT-PCR analysis (Fig.
5). The reliability of microarray results was further con-
firmed by RT-PCR analysis of 10 genes for hypothetical
proteins, 2 for zinc finger proteins, 3 for unknown pro-
teins and 7 genes that were highly expressed in embryoid
bodies (Fig. 4, 5, 6). This similarity in the results con-
firmed the reliability of the microarray studies.
As forty-six of the 194 genes (Table 9/ see additional file
9) identified by microarray showed no significant differ-
ence by MPSS analysis, it was concluded that microarray
and MPSS assays may be different in sensitivity or there
was variability in the production of embryoid bodies. To
address this issue and to determine if the differences
observed by microarray were reliable, we used a second
microarray platform to examine gene expression in the
same samples. Interestingly 33 of the 46 genes showed
overexpression in WiCell derived EBs using Agilent
human 22 k oligo-arrays (Table 9/ see additional file 9).
This suggested that different methods have different sen-
sitivities and it is important to use multiple methods to
confirm expression.
The expression of the remaining 13 genes detected as
overexpressed by microarray studies using a custom built
microarray but not by MPSS or by Agilent microarrays was
RT-PCR analysis of some overexpressed genes and novel  genes in PEB and EB derived from BG02 compared to ES Figure 4
RT-PCR analysis of some overexpressed genes and novel 
genes in PEB and EB derived from BG02 compared to ES. 
RT-PCR analysis of novel genes in PEB and BG02 EB com-
pared to respective ESC. Total RNA derived from both the 
ES and EB cell lines (BG02 and WiCell lines) were used and 
RT-PCR performed as described in Fig. 2 legend. G3PDH 
mRNA served as an internal control.BMC Developmental Biology 2005, 5:22 http://www.biomedcentral.com/1471-213X/5/22
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tested by RT-PCR analysis (Fig 4). Of the thirteen genes, 9
were confirmed by RT-PCR analysis further confirming
the differential sensitivity of various arrays and other
large-scale analytical methods.
Gene expression profile of Day 21 BG02-EB
Our results identified a large set of genes that are differen-
tially modulated as cells differentiate to form embryoid
bodies over a period of two weeks. To examine whether
the same set of genes could be used to assess differentia-
tion of hESC at twenty-one day of differentiation, we
examined gene expression using RNA prepared from Day
21 embryoid bodies. For these studies, undifferentiated
hESC (BG02-ESC) cells were used to generate EBs by a
brief exposure to collagenase IV and small clusters of cells
were obtained by scraping with a pipette. ES cells were dif-
ferentiated for 13 and 21 days, harvested to prepare total
RNA and analyzed by hybridization to microarrays. We
found that a majority of ESC specific genes that were
down modulated as cells differentiated for thirteen days
were further down modulated as a result of differentiation
to day 21 BG02-EB (data not shown). Among 194 genes
overexpressed in day 13 BG02-EB and PEB, thirty-three
genes showed a decrease in fold expression at day 21
BG02-EB. However, other than COL1A2, which was down
modulated from 27 fold to 3 fold, none showed any
marked decrease. The remaining genes were either not
expressed or did not show any change in the expression
(data not shown).
We previously reported that eight early differentiation
marker genes were expressed in hESC, which were further
upregulated in hEBs as determined by EST enumeration
[28]. Therefore, in this study we examined their expres-
sion at day 21 of differentiation. For this experiment gene
expression between BG02 ES was compared with day 13
BG02-EB and day 21 BG02-EB. We found that six of these
genes were markedly down modulated in day 21 BG02-EB
(Table 10/ see additional file 9) compared to day 13EB
and PEB. The other two genes showed minor or no signif-
icant change.
RT-PCR analysis of some novel genes over expressed in PEB  and EB derived from BG02 compared to ES Figure 5
RT-PCR analysis of some novel genes over expressed in PEB 
and EB derived from BG02 compared to ES. RT-PCR analysis 
of six novel genes in EB confirmed by MPSS. Total RNA 
derived from both the ES and EB cell lines (BG02 and WiCell 
lines) were subjected to RT-PCR analysis as described in Fig. 
2 legend. G3PDH mRNA amplified from these samples 
served as an internal control.
RT-PCR analysis of some distinctly over expressed genes in  EB Figure 6
RT-PCR analysis of some distinctly over expressed genes in 
EB. RT-PCR analysis of some distinctly overexpressed genes 
in EB as identified by microarray analysis. Marked overex-
pression in EB is clearly documented in the figure. Total RNA 
derived from both the ES and EB cell lines (BG02 and WiCell 
lines) were subjected to RT-PCR analysis as described in Fig. 
2 legend. G3PDH mRNA amplified from these samples 
served as an internal control.BMC Developmental Biology 2005, 5:22 http://www.biomedcentral.com/1471-213X/5/22
Page 9 of 16
(page number not for citation purposes)
In addition, expression of 11 known EB specific genes that
were shown to be overexpressed in both day 13 BG02-EB
and pooled EB (supplementary table 4S and 5S or see
additional file-8) also examined in day 21 BG02-EB. Inter-
estingly, all of them were down modulated in day 21
BG02-EB (Supplementary table 4S or see additional file-
8)
Additionally, we examined the status of genes that were
upregulated in day 21EB but not in ES or day 13 BG02-EB.
Genes related to cytokeratin and hair keratin (e.g., KRT17,
KRT20, and IVL), which are responsible for structural
integrity showed higher expression in day 21EB compared
to BG02ES or day 13EB. In addition, genes related to
mature tissues were exclusively upregulated in day 21EB
but not in ES and day 13 BG02-EB (Supplementary Table
4S or see additional file-8) indicating that additional dif-
ferentiation markers can be used to distinguish early vs.
late EBs.
While most genes followed an expected pattern of change
in expression in day21 EB, Nanog showed a reverse pat-
tern of expression. On day 13 its expression level was sig-
nificantly reduced compared to BG02-ES, however, on
day 21EB an increased expression was observed compared
to day 13 BG02-EB. Levels were almost similar to those in
BG02-ESC samples (data not shown). Downmodulation
of Nanog in day 13-EB was confirmed by RT-PCR analysis
(Fig 7) though its upregulation in Day 21 samples did not
match the RT-PCR results (see discussion). The downreg-
ulation in nanog followed the downregulation of Oct 3/4
and TERT and other ES specific genes (Figure 7 and data
not shown). In addition, although Sox 2 gene showed a
decrease in expression in pooled EB compared to pooled
ESC but it didn't show any change in expression pattern
from BG02ES to day 13 BG02-EB and day 21 BG02-EB
(data not shown). Expression of Sox-2 gene was also con-
firmed by RT-PCR and immunocytochemistry analyses
(Fig.7 and Fig. 8). Both analyses demonstrated that Sox2
is expressed in day13 and day 21EBs. Oct3/4 protein
expression was used as a control that did not show expres-
sion in Sox-2 expressing cells confirming that the Sox-2
expression represented induction in a newly differentiated
population rather than in persistent ESC.
These results indicate that KRT8, KRT18, TUBB5, ACTC,
SERPINH1, TUBB4, KRT19, HAND1, FN1, ENO1,
COL1A2, COL5A2, COL4A2 and other identified markers
may serve as a indicators of early and late stages of differ-
entiation as they were further markedly down regulated
on day 21 compared to day 13 of differentiation. In con-
trast, genes such as KRT17, KRT20, IVL, NPHP3, CAPN1,
and CNTN6 are markers of later stage of differentiation as
they are overexpressed in day 21 compared to day 13 of
differentiation. Thus microarray studies can distinguish
between ES cells and embryoid bodies as well as between
early and late stage embryoid bodies.
Discussion
Our results show that large-scale oligonucleotide based
microarrays can be used to distinguish between undiffer-
entiated hESC and differentiating hEBs. Two sets of mark-
ers can be distinguished in a set of 'stemness" genes that
are present at higher levels in undifferentiated cells whose
levels are reduced as cells differentiate and a complemen-
tary set of genes that are absent or present at low levels in
hESC and are upregulated as cells differentiate. The set of
genes that are upregulated as cells differentiate include
known as well as unknown genes. This pattern of gene
expression was confirmed by a variety of independent
means including microarray using a second independent
array set, comparison with MPSS using similar samples
and by RT-PCR. The combined set of upregulated and
down regulated genes will serve as a sensitive indicator of
the state of hESC and the novel sets of genes identified are
RT-PCR analysis of some ES and EB specific genes Figure 7
RT-PCR analysis of some ES and EB specific genes. RT-PCR 
analysis of ES and EB specific genes in day 14 and day 21 
BG02-EB and BG02-ES samples. Total RNA derived from 
both the ES and EB cell lines (BG02-ES and EB) were sub-
jected to RT-PCR analysis as described in Fig. 2 legend. 
G3PDH mRNA amplified from these samples served as an 
internal control.BMC Developmental Biology 2005, 5:22 http://www.biomedcentral.com/1471-213X/5/22
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likely candidates that may participate in regulating the
process of differentiation.
In our previous study we demonstrated over expression of
a set of 92 genes in six undifferentiated ESC cell [28].
Expression of almost all of the genes was confirmed in the
BG02-ES and pooled hESC used in the present study. The
present study further refines the set of stemness genes to
identify those that are rapidly down-regulated as ES cells
differentiate. We show that 77 of these are down modu-
lated when differentiated to embryoid bodies using
undifferentiated BG02-ES. Further differentiation of
BG02-ES to day 21 BG02-EB showed consistency in down
modulation of many of these. This refined subset of pre-
viously identified stemness genes can be used to monitor
the transition of undifferentiated pluripotent human
embryonic stem cells to differentiated embryoid bodies.
Analyzing the pattern of gene expression, we would sug-
gest that ES specific genes such as Lin-28, PSIP2, PITX2,
DNMT3B, and Galanin whose downregulation is seen in
both lines and confirmed by EST scan and microarray rep-
resent good initial candidates to assess the ES cell state.
Furthermore, LEFTB and CER1, inhibitors of nodal signal-
ing, which were downmodulated as ES cells differentiated
(data not shown) in addition to other members of the
TGFβ signaling family may be sensitive indicators of ESC
differentiation. Oct3/4, Sox-2 and nanog in contrast while
expressed by ES cells may not be as good in assessing ES
cell to embryoid body differentiation. While Oct-3/4
expression declined markedly in both BG02 EBs and
pooled ES derived EBs compared to ES the decline was
slow and not as rapid as that of other genes. This may be
because Oct3/4 expression persists in germ cells that are
derived from ESC [31]. Likewise our analysis of nanog
showed variable results and there was a discrepancy
between the microarray and PCR results and we noted an
increase in nanog levels in Day 21 BG02-EB samples by
microarray. The reason for this difference is not clear. It is
possible that microarray is detecting one of the eleven
processed pseudogenes for nanog and that its expression
on day 21 represents crosshybridization. Alternatively,
nanog expression may be increased as a result of differen-
tiation. This conclusion is supported by a recent report
that nanog is expressed in mature tissues [32]. We have
Immunocytochemistry of Oct-3/4 and Sox-2 in ES and EB Figure 8
Immunocytochemistry of Oct-3/4 and Sox-2 in ES and EB. Immunocytochemistry of Oct3/4 and Sox-2 in ES and EB. Human 
neural progenitor cells derived from ES cells were stained with various antibodies. (A) All neural progenitor cells are Oct3/4 
negative and (B) most of these cells are positive for Sox2. DAPI staining shows every cell in (A) and (B).BMC Developmental Biology 2005, 5:22 http://www.biomedcentral.com/1471-213X/5/22
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confirmed that nanog expression is indeed present in
some germ cells and early neuronal populations (data not
shown). These tests were performed by RT-PCR using
multiple primers and double label immunocytochemistry
(results not shown). Future studies will examine expres-
sion of nanog in EBs using specific antibody and its func-
tion in differentiated cells. At present we recommend that
nanog expression should be confirmed by PCR or immu-
nocytochemistry and it should not be included as an ini-
tial indicator of the ES cell state and differentiation.
In addition to confirming the downregulation of hESC
specific genes our study identified a set 333 genes that
were uniquely overexpressed at ≥ 3 fold in day 13 BG02
EB compared to undifferentiated BG02 ES cell lines. Out
of these 333 genes 194 genes also showed ≥ 3 fold over
expression in EB samples prepared from WiCell lines. This
significant similarity of unique genes in BG02 and WiCell
line derived EBs suggest that this subset of genes can be
classified as EB specific (induced as ESC differentiate) and
that embryoid bodies derived from different ES cells
maintain significant similarity with each other. These EB
specific genes like the ES cell specific genes may be useful
in distinguishing EBs from ES cells.
A detailed analysis of upregulated genes in EB indicated
that a) differentiation genes, b) cell signaling, cellular
process and cell cycle genes, c) cytoskeleton or cell motil-
ity genes and d) metabolism and DNA and RNA related
genes were modulated. In addition, 27 hypothetical
genes, 8 unknown genes and 2 zinc finger genes were
upregulated in BG02 derived EB and WiCell lines derived
EB. The status of upregulated genes identified by
microarray studies was confirmed by MPSS analysis.
Among 194 genes, 148 genes showed higher expression in
EB by MPSS analysis. Overexpression of 33 genes in EBs
compared to HuURNA was confirmed using alternate
large-scale array. The expression of a subset of the remain-
ing 13 genes was confirmed by RT-PCR analysis. These
results suggest that microarray analysis is a useful
complement to MPSS and may identify a overlapping but
non-identical set of genes. Among the genes that were
upregulated in both EB samples is HAND1 (heart and
neural crest derivatives 1). HAND1 was dramatically up
regulated (40 fold compared to 6 fold in undifferentiated
ES cells). HAND1 belongs to basic helix-loop-helix family
of transcription factor, may be required for early trophob-
last differentiation as well as the differentiation of heart
tissue [33].
Additionally we noted that several markers of early differ-
entiation such as keratin, actin and beta tubulin, which
are present at low levels in ESC, were dramatically upreg-
ulated as EBs differentiated. We suggest that these markers
can serve as sensitive indicators of the process of differen-
tiation and when coupled with the down regulation of
ESC markers may reliably distinguish the state of ES cell
cultures. Future experiments will assess the sensitivity of a
combination of markers identified in this study to tempo-
rally profile the process of differentiation. A recent study
(34) has compared gene expression of 24-marker genes
between EBs differentiated with eight different growth fac-
tors and hESC. Similar to our observation by microarray
analysis, this study showed over expression of genes
related to ectoderm differentiation such as Keratin-8, Ker-
atin-18 and Keratin-19 when differentiated by retinoic
acid. A highly significant upregulation of mesodermal
related genes e.g., HAND1 was also observed which con-
firms our observation.
Our results further show that many genes that are induced
or upregulated as EBs differentiate remain elevated at Day
21 of differentiation. These genes represent good markers
for distinguishing differentiated cells from ESC. In addi-
tion we noted that several genes showed differential
expression when levels of expression in Day 13 and Day
21 BG02-EB's was compared. Thirty-three of the 194
genes upregulated at Day 13 were down modulated at
day21 EB. Other genes such as NPHP3, CAPN1, and
CNTN6 were up regulated in day 21 BG02-EB's when
compared to day 13 EB. These later appearing genes may
reflect additional derivatives that appear as EBs undergo
further differentiation. These later appearing markers
along with markers that are down regulated can be used to
distinguish early from late EBs.
A recent study has characterized differences in gene
expression between mouse and human ESC (35). This
study identified differences between mouse and human
ESC and reported that differences were species specific
rather than arising from differing culture conditions. In
our current study, while the expression of many genes was
similar in rodent and human cells significant differences
were found. For example the expression of vimentin,
eomesodermin, SSEA4, AFP, IL6ST and HEB was found in
hESC but not in mouse ES cells.
The large oligonucleotide arrays have allowed us to build
a comprehensive data set that includes hundreds of genes
(both novel and unknown) that are either upregulated or
downregulated as hESC differentiate. The list of genes has
been validated by testing on different cells lines, testing
using different oligonucleotide sequences to different
regions of the genes and testing arrays used in different
formats. Our results show clearly that while small
differences exist as different techniques are used the core
set of markers is quite robust, the differences in expression
quite large and are readily detectable even using a rela-
tively insensitive method such as a microarray. Our results
show further that restricting the analysis to only this set ofBMC Developmental Biology 2005, 5:22 http://www.biomedcentral.com/1471-213X/5/22
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genes as would be necessary in focused array does not
reduce the sensitivity of the assessment. Indeed, based on
our results we would suggest that an order of magnitude
fewer genes may be sufficient if they are appropriately
selected from the lists. We have recently developed a
focused array that includes genes that are down regulated
as hESC differentiate as well as those that are induced as
cells differentiate [36].
Conclusion
In conclusion, a similar pattern of gene expression profile
was observed in two differentiated embryoid body sam-
ples derived from different embryonic stem cell lines. A
consistent and marked downmodulation of most of the
"stemness" genes was observed in embryoid bodies indi-
cating that relative levels of these genes can be used to
assess the transition of ES cells to embryoid bodies. In
addition, we show that 194 unique genes are over
expressed in EB and that this subset serves as a comple-
ment to the previously characterized "stemness genes" in
assessing the degree of differentiation of ES lines and dif-
ferentiating embryoid bodies. Further validation and con-
firmation of these data with MPSS and RT-PCR
documents the usefulness of high throughput microarray
technology and identifies an additional set of previously
unknown genes that are likely important in regulating the
process of differentiation. These EB enriched genes in
combination with downmodulated stemness genes may
serve as biomarkers to monitor the transition of undiffer-
entiated human embryonic stem cells to differentiated
embryoid bodies.
Methods
Isolation and growth of ES cells and differentiation into EB
BG02 ESC were derived at Bresagen Inc., Athens, GA (37)
and pooled samples (WiCell lines: WA01, WA07 and
WA09, also termed as GE01, GE07 and GE09 respectively)
were derived at Wisconsin Alumni Research Foundation,
Wicell Research Institute, Madison, WI. (38). ESC were
maintained on inactivated mouse embryonic fibroblasts
(MEF) feeder cells in Dulbecco's Modified Eagle's
Medium (DMEM) supplemented with 15% fetal bovine
serum (FBS), 5% knockout serum replacement (KSR), 2
mM non-essential amino acids, 2 mM L-glutamine, 50 µg/
ml Penn-Strep (all from Invitrogen, Corporation,
Carlsbad, CA), 0.1 mM β-mercaptoethanol (Specialty
Media), and 4 ng/ml of basic fibroblast growth factor
(bFGF, Sigma). These cell lines were maintained as previ-
ously described [3,7,39]. Cells were passaged by incuba-
tion in cell dissociation buffer (Invitrogen), dissociated,
and then seeded at about 20000 cells/cm2. hESC har-
vested for studies were found to be free of MEF as previ-
ously described [30,35].
Embryoid body outgrowths (hEB) were prepared from
BG02 cells and pooled samples of ESC (pooled EB) as
described [23,30]. Briefly, confluent plates of undifferen-
tiated hESC were used to generate hEBs by a brief expo-
sure to collagenase IV and small clusters of cells were
obtained by scraping with a pipette. Cell clusters were
resuspended in differentiation medium (KO-DMEM sup-
plemented with glutamine, NEAA, and BME as described
for the undifferentiated ESC [8], with 20% FBS in place of
20% serum replacement (SR) and no preconditioning by
MEFs) and transferred to individual wells of low adhesion
6-well plates (Costar). After 4 days in suspension, cells
were transferred to tissue culture 6-well plates pre-coated
with gelatin. Cells were harvested for the preparation of
total RNA from BG02 EB on day 13 and day 21 and from
pooled EB on day 14. Based on morphological evaluation
undifferentiated hESC were also identified in certain
regions of differentiating colonies even after 21 days of in
vitro culture, suggesting that hESC can undergo several cell
divisions in "differentiation promoting" culture condi-
tions while maintaining their pluripotent phenotype [40].
Microarray studies
High quality oligonucleotide glass arrays were produced
containing a total of 16,659 seventy-mer oligonucleotides
chosen from 750 bases of the 3' end of each ORF (Operon
Inc. Valencia, CA). The array includes probes for 2121
hypothetical proteins and 18-expressed sequence tags
(ESTs) and spans approximately 50% of the human
genome (Operon Inc., Valencia, CA). The arrays were pro-
duced in house by spotting oligonucleotides on poly-L-
lysine coated glass slides by Gene Machines robotics
(Omnigrid, San Carlos, CA). We have followed the
MIAME (minimum information about a microarray
experiment) guidelines for the presentation of our data
[41].
i) Probe preparation
Total RNA was isolated from hESC lines derived pellet by
using Trizol reagent (Invitrogen). Total human universal
RNA (huURNA) isolated from a collection of adult
human tissues to represent a broad range of expressed
genes from both male and female donors (BD Bio-
sciences, Palo Alto, CA) served as a universal reference
control in the competitive hybridization. Labeled cDNA
probes were produced as described [42]. Briefly, 5 µg of
total RNA was dissolved in 12 µl of DEPC water and incu-
bated at 70°C for 5 minutes along with 1 µl of aminoallyl-
oligo dT (5' amino-modified) primer and quickly chilled
for 3 minutes. Then, 2 µl 10× first strand buffer, 1.5 µl SSII
enzyme (Stratagene, La Jolla, CA), 1.5 µl 20× aminoallyl
dUTP and 2 µl of 0.1 M DTT were added and incubated for
90 minutes at 42°C. After incubation, volume of the reac-
tion mixture was raised to 60 µl with 40 µl of DEPC water.BMC Developmental Biology 2005, 5:22 http://www.biomedcentral.com/1471-213X/5/22
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cDNA was purified by MinElute column (Qiagen, Valen-
cia, CA). 300 µl of Binding buffer PB was added to the
coupled cDNA, and the mixture applied to the MinElute
column, and centrifuged for 1 min at max speed. After
discharging the flow-through, 600 µl of washing buffer PE
was added to the column, and centrifuged for 1 min at
max speed. The flow-through was discharged and the
washing repeated. Then the columns were placed into a
fresh eppendorf tube and 15 µl elution buffer added to the
center of the membrane, incubated for 1 min at room
temperature, centrifuged for 1 min at max speed and
probe collected. The probe was dried in speed-vac for 16
minutes. Finally, 5 µl of 2× coupling buffer and 5 µl Cy3
and Cy5 dye mixed into the control (huURNA) and exper-
imental cDNAs (huES cell-derived) and incubated at
room temperature in dark for 90 minutes. After incuba-
tion, the volume was raised to 60 µl by 50 µl DEPC water
and then cDNA was purified by MinElute column and
eluted with 13 µl elution buffer by centrifugation.
ii) Hybridization
For hybridization, 36 µl hybridization mixture [26 µl
cDNA mixture, 1 µl (10 µg) COT-1 DNA, 1 µl (8–10 µg)
poly(dA), 1 µl yeast tRNA (4 µg), 6 µl 20× SSC and 1 µl
10% SDS] was pre-heated at 100°C for 2 minutes and
cooled for 1 minute. Total volume of probe was added on
the array and covered with cover slip (22 mm × 40 mm).
Slides are placed in hybridization chamber and 20 µl
water was added to far end of slide (to maintain humid-
ity), and incubated overnight (10–16 hours) at 65°C.
Slides were then washed for 2 minutes each into 2× SSC,
1× SSC and 0.1× SSC and spin-dried.
iii) Data filtration, normalization, and analysis
Microarray slides were scanned in both Cy3 (532 nm) and
Cy5 (635 nm) channels using Axon GenePix 4000B scan-
ner (Axon Instruments, Inc., Foster City, CA) with a 10-
micron resolution. Scanned microarray images were
exported as TIFF files to GenePix Pro 3.0 software for
image analysis. The raw images were collected at 16-bit/
pixel resolutions with 0 to 65,535 count dynamic range.
The area surrounding each spot image was used to calcu-
late a local background and subtracted from each spot
before Cy5:Cy3 ratio calculation. The average of the
resulting total Cy3 and Cy5 signal gave a ratio that was
used to normalize the signals. Each microarray
experiment was globally normalized to make the median
value of the log2-ratio equal to zero. The normalization
process corrects for dye bias, PMT (Photo multiplier tube)
voltage imbalance, and variations between channels in
the amounts of the labeled cDNA probes hybridized. The
data files representing the differentially expressed genes
were then created.
For advanced data analysis, data files (in gpr format) and
image (in jpeg format) were imported into mAdb (micro-
array database), and analyzed by software tools provided
by National Institutes Health Center for Information
Technology. Spots with confidence interval of 99 (>3
fold) with at least 150-fluorescence intensity in either
channel or 30 µm spot size were considered as good qual-
ity spots for analysis. These advanced filters prevented the
potential effect of the poor quality spots in data analysis.
RT-PCR analysis
Total RNA was isolated from both ES and EB cell pellets
using the RNeasy Qiagen mini protocol and kit (Qiagen,
Valencia, CA). cDNA was synthesized using 1 µg of total
RNA in a 20 µl reaction. Superscript II (Invitrogen,
Carlsbad, CA) and oligo (dT)12–18  primers were used
according to the manufacturer's instructions (Invitrogen).
The list of primers used for RT-PCR was described in sup-
plemental table 6S (see additional file 8) and annealing
conditions are described previously [35].
MPSS analysis and EST enumeration
We compared microarray results with published MPSS
and EST enumeration databases as previously described
[30,23]. In brief, MPSS was performed using RNA samples
from feeder free cultures of differentiated (day 14 pooled
EB derived from WiCell lines) and undifferentiated (pas-
sage 35–45) WA01, WA07, and WA09 lines (pooled ESC:
pooled samples of ESC). The mRNA was converted to
cDNA and digested with DpnII. The last DpnII site and the
downstream 16 bases were cloned into Megaclone vectors
and their sequences (signatures) were determined accord-
ing to the MPSS protocol [43,44]. A total of 2,403,315 and
2,591,008 sequences were read for pooled ESC and
pooled EB respectively, and 36,498 and 26,599 unique
signatures were identified. The abundance for each signa-
ture was converted to transcripts per million (tpm) for the
purpose of comparison between samples. Signatures at an
abundance of less than 4 tpm in at least one of samples or
those that were not detected in at least two runs across
multiple samples were removed and a total of 24, 229
(pooled ES) and 17,970 (pooled EB) sequences were ana-
lyzed further.
EST frequency counts of genes expressed in EB samples
were performed as described [23]. Briefly, cDNA libraries
of hESC lines (WiCell WA01, WA07, and WA09) grown in
feeder free conditions and that of EB's derived from the
same cell lines were constructed and submitted for EST
sequencing. The EST sequences were assembled into over-
lapping sequence assemblies and mapped to the UniGene
database of non-redundant human transcripts. Expression
levels were assessed by counting the number of ESTs for a
particular gene that was derived from the undifferentiated
hESC and comparing them to the number of ESTs derivedBMC Developmental Biology 2005, 5:22 http://www.biomedcentral.com/1471-213X/5/22
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from the EB samples. Statistical significance was deter-
mined using the Fisher Exact Test [45] using a p-value of
p≤ 0.05.
MPSS signature classification and annotation
To generate a complete, annotated human signature data-
base, we extracted all the possible signatures ("virtual sig-
natures") from the human genome sequence (hg16, July
2003, Golden Path, UCSC) and the human Unigene
sequences (Unigene build #163). The extracted virtual
signatures were classified and ranked according to their
positions and the presence of polyA tail and polyA signal
features in the source sequence as described [46].
Immunocytochemistry
Neural cells derived from hESC were processed for immu-
nocytochemistry as described previously [47]. The human
Oct3/4 (1:1000) and Sox2 (1:1000) antibodies were
obtained form R&D Systems. Bis-benzamide (1:1000,
Sigma) was used to identify the nuclei. The secondary
antibodies anti-mouse IgG 568 (1:500) and anti-goat IgG
568 (1:500) were purchased from Molecular Probes.
Images were captured on an Olympus fluorescence
microscope.
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